Back to results
US 2019/0100551 A1Published application
5-fluorouridine monophosphate cyclic triester compounds
AssigneeNucorion Pharmaceuticals, Inc.
InventorLin Zhi
Life of this patent
Estimating the term…
Abstract
Provided herein are 5-fluorouridine monophosphate cyclic triester compounds, their preparation and their uses, such as treating hepatocellular carcinoma and other types of cancer.
Claims20
A compound having the structure of Formula Ia or Ib:
- or a stereoisomer or a pharmaceutically acceptable salt thereof,
- wherein:
- R1 is selected from a group of an optionally substituted aryl, and an optionally substituted heteroaryl;
- R2 is selected from a group of H, an optionally substituted C1-C10 heteroalkyl, an optionally substituted C1-C10 acyl, an optionally substituted C1-C10 heteroacyl, an optionally substituted C1-C10 alkyl-C-carboxy, and an optionally substituted C1-C10 alkyl-C-amido;
- R3 is selected from a group of H, OH, and an optionally substituted C1-C10 acyloxy;
- and
- R4 is selected from a group of H, an optionally substituted C1-C10 heteroalkyl, and an optionally substituted C1-C10 acyl.
4 more elements
Dependencies are inferred from the claim text.